Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Oct 28, 2019
    Two Foundations To Pay $6 Million To Resolve Kickback Allegations Involving Co-Pays
  • Oct 28, 2019
    FTC Releases Proposed Consent Agreement Over Employee-written Online Product Reviews
  • Oct 25, 2019
    House Bill Introduced To Remove Tax Deduction for Drug Ads, Other Promotional Activities
  • Oct 25, 2019
    Ky. Receives $17 Million Settlement Over Claims for Birth Control Drugs
  • Oct 24, 2019
    States Reach $700 Million Settlement With Reckitt Over Suboxone Marketing
  • Oct 21, 2019
    Survey of Open Payment Data Finds Amount of Payments, Number of Physicians Holding Steady
  • Oct 21, 2019
    Mississippi Hospitals Sue Opioid Makers
  • Oct 21, 2019
    J&J, Ethicon To Pay $116 Million To Resolve Lawsuit Over Transvaginal Surgical Mesh Promotion
  • Oct 12, 2019
    Appeals Court Rejects Delay of Bellwether Opioid Trial
  • Oct 4, 2019
    Survey Finds Fewer U.S. Physicians Have In-person Meetings with Pharma Reps
  • More

Good Clinical Practice

  • Nov 2, 2019
    FDA Is Moving IND Safety Reporting to FAERS
  • Nov 1, 2019
    FDA Called on To Make Clinical Trial Risk-based Monitoring the Gold Standard
  • Oct 25, 2019
    CTTI Issues Recommendations for Using Real World Data for Eligibility Criteria, Recruiting Subjects
  • Oct 25, 2019
    Six Charged With Insider Trading Involving Trial Info
  • Oct 24, 2019
    European Trials@Home Project Launched
  • Oct 23, 2019
    EU Provides GCP Guidelines for ATMP Clinical Trials
  • Oct 21, 2019
    SACHRP Provides Questions for IRBs and Potential Subjects To Ask Regarding Pay-to-Participate Research
  • Oct 21, 2019
    UK Plans Legislation on Trials Post Brexit
  • Oct 15, 2019
    Cancer Trial Patient Reimbursement Bill Introduced in Wisconsin Senate
  • Oct 13, 2019
    Study Finds Use of Real World Data Can’t Replace Need for Traditional Clinical Trials
  • More

U.S. Food Labeling

  • Nov 1,2017
    FDA Is Rethinking Soy Protein, CHD Health Claim
  • Oct 25,2017
    FDA Is Soliciting Input on Biotechnology Education
  • Oct 25,2017
    Better Oversight of ‘Organic’ Imports Is Needed
  • Oct 25,2017
    Groups Ask for Syncing Compliance Dates
  • Oct 25,2017
    Use of ‘All Natural’ Is Addressed in Settlement Agreement
  • Oct 25,2017
    ‘Misleading’ Labels Are Actually True
  • Oct 24,2017
    Firms Align Date Labeling, Waste Reduction Efforts
  • Oct 24,2017
    FDA Finds Problems with Misbranded Foods, Supplements
  • Oct 24,2017
    Bakery Is Cited for Misbranded, Adulterated Products
  • Oct 3,2017
    FDA Proposes To Extend Nutrition Facts Label Compliance Date
  • More

FDA Regulation & Enforcement

  • Jul 10, 2023
    FTC Sets Policy on Endorsements
  • Jul 5, 2023
    Drug Wholesale Firm Owner Charged in Scheme To Illegally Distribute HIV Drugs Worth More Than $150M
  • Jul 5, 2023
    Final Guidance on Quantitative Efficacy and Risk Info in DTC Promotions Is Little Changed From Draft
  • Jun 30, 2023
    FDA Triples Number of Subjects for Proposed FOPL Survey
  • Jun 29, 2023
    Ex-DePuy Sales Rep Charged With Defrauding Hospital, Lying to FBI About Sterilization Interference
  • Jun 28, 2023
    Connecticut To Require Companies With Sale Reps To Register
  • Jun 14, 2023
    DOJ Opposes Supplement Company’s Motion To Dismiss Complaint in Forfeiture Following Kratom Seizure
  • Jun 14, 2023
    New Jersey Oncologist Pleads Guilty to Illegal Resale of Prescription Drugs Through Diversion Scheme
  • Jun 13, 2023
    OPDP Issues First Enforcement Letter in a Year
  • Jun 12, 2023
    Literature Review Finds Interpretive FOPL Is ‘More Comprehensible and Equitable’
  • More

Medical Devices

  • Jul 30, 2020
    FDA Announces Medical Device User Fee Increases for FY 2021; PMA, 510(k) Fees To Rise More Than 7%
  • Jul 28, 2020
    Device False Advertising Claims Dismissed
  • Jul 22, 2020
    FDA Issues EUA for COVID-19 Sample Pool Test, Provides Enforcement Discretion for Viral Transport Media
  • Jul 20, 2020
    FDA Delays Enforcement of Premarket Approval Mandates for Some HCT/Ps Through May 2021 Due to COVID-19
  • Jul 10, 2020
    FDA To Use COVID-19 Risk Assessment System As It Restarts Domestic Inspections; Most Will Be Preannounced
  • Jul 8, 2020
    Enforcement Discretion for Some Class I, Unclassified Device UDI Requirements Extended by Two Years
  • Jul 2, 2020
    Public Citizen Blasts FDA’s Approval, Clearance and Oversight of Implanted Spinal Cord Stimulators
  • Jul 1, 2020
    Novartis, Subsidiaries Settle Foreign Corrupt Practices Act Allegations for Over $345 Million
  • Jun 24, 2020
    CDRH, CDER Provide Guidance on COVID-19’s Effect on Regulatory, Policy Issues Related to Devices
  • Jun 17, 2020
    FDA’s Revised EUA Templates for COVID-19 Test Developers Cover Tests To Be Used With Sample Pooling
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.